Visceral Obesity and Colorectal Surgery

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Francesco Volonté, MD, University Hospital, Geneva
ClinicalTrials.gov Identifier:
NCT01620697
First received: June 13, 2012
Last updated: June 15, 2012
Last verified: June 2012
  Purpose

While perirenal fat measurement is an easy reproducible surrogate of visceral fat, its value as independent parameter in predicting postoperative complications after colorectal resection remains poorly investigated.

The investigators want to test the value of perirenal fat as surrogate of visceral obesity as risk factor for morbidity in colorectal surgery and to compare it to the effect of Body mass index (BMI) and Waist- Hip ratio (WHR).


Condition Intervention
Visceral Obesity
Colorectal Surgery
Risk Factor
Procedure: Colorectal surgery

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Value of Perirenal Fat Surface as a Risk Factor for Morbidity After Elective Colorectal Surgery

Resource links provided by NLM:


Further study details as provided by University Hospital, Geneva:

Primary Outcome Measures:
  • Postoperative complications [ Time Frame: 30 days ] [ Designated as safety issue: Yes ]
    Postoperative complications (Clavien-Dindo classification)


Secondary Outcome Measures:
  • Duration of the operation [ Time Frame: From incision to dressing of the wound ] [ Designated as safety issue: No ]
  • Rate of conversion [ Time Frame: From incision to dressing of the wound ] [ Designated as safety issue: No ]

Enrollment: 224
Study Start Date: January 2009
Study Completion Date: June 2012
Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Perirenal fat Procedure: Colorectal surgery
Colorectal surgery

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

We included all elective colorectal resections for benign, malignant and inflammatory diseases, admitted to the Geneva university hospital, Geneva, Switzerland

Criteria

Inclusion Criteria:

  • elective colorectal resection

Exclusion Criteria:

  • age under 18
  • emergency condition
  • immunosuppression
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01620697

Locations
Switzerland
University Hospital Geneva
Geneva, Switzerland, 1211
Sponsors and Collaborators
University Hospital, Geneva
Investigators
Principal Investigator: Minoa Jung, MD University Hospital, Geneva
Principal Investigator: Francesco Volonte, MD University Hospital, Geneva
Study Chair: Philippe Morel, MD University Hospital, Geneva
  More Information

No publications provided

Responsible Party: Francesco Volonté, MD, MD, University Hospital, Geneva
ClinicalTrials.gov Identifier: NCT01620697     History of Changes
Other Study ID Numbers: FAT-40-GVA
Study First Received: June 13, 2012
Last Updated: June 15, 2012
Health Authority: Switzerland: Ethikkommission

Additional relevant MeSH terms:
Obesity
Obesity, Abdominal
Overnutrition
Nutrition Disorders
Overweight
Body Weight
Signs and Symptoms

ClinicalTrials.gov processed this record on August 28, 2014